脂肪性肝炎-话题@MedSci

#脂肪性肝炎#

121篇内容 | 3310人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1956112, encodeId=bf2c19561127e, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Nat Med：Efruxifermin治疗非酒精性脂肪性肝炎的疗效和安全性分析, objectType=article, longId=214042, objectId=005e214042e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=005e214042e3, replyNumber=0, likeNumber=83, createdTime=2022-01-26, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=005e214042e3, moduleTitle=Nat Med：Efruxifermin治疗非酒精性脂肪性肝炎的疗效和安全性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=005e214042e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956114, encodeId=44b51956114b3, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=J Clincal Gastroenterology：肾功能衰竭与非酒精性脂肪性肝炎患者的死亡率增加有关, objectType=article, longId=214967, objectId=b6cc21496e09, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6cc21496e09, replyNumber=0, likeNumber=74, createdTime=2022-05-05, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6cc21496e09, moduleTitle=J Clincal Gastroenterology：肾功能衰竭与非酒精性脂肪性肝炎患者的死亡率增加有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6cc21496e09)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956122, encodeId=06ae1956122ad, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=J Hepatol：口服FXR激动剂EDP-305治疗非酒精性脂肪性肝炎的疗效, objectType=article, longId=220041, objectId=456022004188, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=456022004188, replyNumber=0, likeNumber=75, createdTime=2022-03-10, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=456022004188, moduleTitle=J Hepatol：口服FXR激动剂EDP-305治疗非酒精性脂肪性肝炎的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=456022004188)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956121, encodeId=94f11956121d7, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=AJG：他汀类药物对非酒精性脂肪性肝炎肝硬化患者的肝细胞癌具有化学预防作用, objectType=article, longId=219990, objectId=7da9219990b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7da9219990b5, replyNumber=0, likeNumber=63, createdTime=2021-12-15, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7da9219990b5, moduleTitle=AJG：他汀类药物对非酒精性脂肪性肝炎肝硬化患者的肝细胞癌具有化学预防作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7da9219990b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956113, encodeId=2d541956113de, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=AJG：与乙型肝炎相比非酒精性脂肪性肝炎导致的肝硬化预后较差, objectType=article, longId=214334, objectId=a50d2143348a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a50d2143348a, replyNumber=0, likeNumber=84, createdTime=2021-09-08, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a50d2143348a, moduleTitle=AJG：与乙型肝炎相比非酒精性脂肪性肝炎导致的肝硬化预后较差, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a50d2143348a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956117, encodeId=cf82195611e80, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Nat Med：Aramchol治疗非酒精性脂肪性肝炎的疗效分析, objectType=article, longId=218294, objectId=f2f42182948a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2f42182948a, replyNumber=0, likeNumber=59, createdTime=2022-04-02, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2f42182948a, moduleTitle=Nat Med：Aramchol治疗非酒精性脂肪性肝炎的疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2f42182948a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956110, encodeId=e1801956110cd, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Clin Gastroenterol H：非酒精性脂肪性肝炎患者体重变化与组织学特征和血液标志物变化之间的关系, objectType=article, longId=210672, objectId=cc052106e2be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc052106e2be, replyNumber=0, likeNumber=63, createdTime=2022-02-02, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc052106e2be, moduleTitle=Clin Gastroenterol H：非酒精性脂肪性肝炎患者体重变化与组织学特征和血液标志物变化之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc052106e2be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956106, encodeId=d2551956106ab, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=NEJM：GLP-1受体激动剂治疗非酒精性脂肪性肝炎（NASH）：脂肪变性和肝损伤显著减轻，但纤维化改善不明显, objectType=article, longId=203520, objectId=4ff9203520a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ff9203520a1, replyNumber=0, likeNumber=76, createdTime=2021-06-20, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ff9203520a1, moduleTitle=NEJM：GLP-1受体激动剂治疗非酒精性脂肪性肝炎（NASH）：脂肪变性和肝损伤显著减轻，但纤维化改善不明显, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ff9203520a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956115, encodeId=983119561154b, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Nat Med：Eruxifermin治疗非酒精性脂肪性肝炎的疗效如何？, objectType=article, longId=215100, objectId=40682151003b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40682151003b, replyNumber=0, likeNumber=78, createdTime=2022-05-16, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40682151003b, moduleTitle=Nat Med：Eruxifermin治疗非酒精性脂肪性肝炎的疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40682151003b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956111, encodeId=582c1956111a1, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Nat Med：XCR1+1型常规树突状细胞：非酒精性脂肪性肝炎的驱动因素, objectType=article, longId=211722, objectId=88a6211e22d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88a6211e22d2, replyNumber=0, likeNumber=80, createdTime=2021-10-13, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88a6211e22d2, moduleTitle=Nat Med：XCR1+1型常规树突状细胞：非酒精性脂肪性肝炎的驱动因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88a6211e22d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956109, encodeId=d753195610928, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=JAHA：伴有非酒精性脂肪性肝炎的肥胖患者心脏形态、功能和血流动力学改变, objectType=article, longId=209940, objectId=9601209940b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9601209940b7, replyNumber=0, likeNumber=87, createdTime=2021-10-13, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9601209940b7, moduleTitle=JAHA：伴有非酒精性脂肪性肝炎的肥胖患者心脏形态、功能和血流动力学改变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9601209940b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956100, encodeId=6d3e1956100fb, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Hepatology: 白细胞介素22可以通过改善嗜中性粒细胞驱动性非酒精性脂肪性肝炎的炎症程度, objectType=article, longId=200471, objectId=d64c2004e17a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d64c2004e17a, replyNumber=0, likeNumber=73, createdTime=2020-12-13, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d64c2004e17a, moduleTitle=Hepatology: 白细胞介素22可以通过改善嗜中性粒细胞驱动性非酒精性脂肪性肝炎的炎症程度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d64c2004e17a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956103, encodeId=c59f195610309, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Hepatology: 肝功能不全患者缺乏肝再生蛋白会促进非酒精性脂肪性肝炎和纤维化的发生, objectType=article, longId=203256, objectId=af3e20325689, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af3e20325689, replyNumber=0, likeNumber=80, createdTime=2021-03-15, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af3e20325689, moduleTitle=Hepatology: 肝功能不全患者缺乏肝再生蛋白会促进非酒精性脂肪性肝炎和纤维化的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af3e20325689)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956093, encodeId=ff7a19560934f, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=非酒精性脂肪性肝炎（NASH）：歌礼生物的ASC40显著降低肝脏脂肪，响应率达61％, objectType=article, longId=196200, objectId=2de719620026, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2de719620026, replyNumber=0, likeNumber=69, createdTime=2020-11-19, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2de719620026, moduleTitle=非酒精性脂肪性肝炎（NASH）：歌礼生物的ASC40显著降低肝脏脂肪，响应率达61％, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2de719620026)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956101, encodeId=436d195610182, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Cell:中山大学苏士成/许小丁/高志良发现表观遗传对于非酒精性脂肪性肝炎的关键调控作用, objectType=article, longId=200761, objectId=c493200e6155, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c493200e6155, replyNumber=0, likeNumber=77, createdTime=2021-02-16, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c493200e6155, moduleTitle=Cell:中山大学苏士成/许小丁/高志良发现表观遗传对于非酒精性脂肪性肝炎的关键调控作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c493200e6155)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956108, encodeId=d736195610825, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=NEJM：皮下注射司美鲁肽对非酒精性脂肪性肝炎的疗效, objectType=article, longId=208994, objectId=4de32089940d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4de32089940d, replyNumber=0, likeNumber=106, createdTime=2021-06-14, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4de32089940d, moduleTitle=NEJM：皮下注射司美鲁肽对非酒精性脂肪性肝炎的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4de32089940d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956104, encodeId=d2f3195610401, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=FDA批准候选药物lanifibranor进入III期临床，以治疗非酒精性脂肪性肝炎（NASH）, objectType=article, longId=203274, objectId=cfcb2032e4c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfcb2032e4c1, replyNumber=0, likeNumber=71, createdTime=2020-12-01, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfcb2032e4c1, moduleTitle=FDA批准候选药物lanifibranor进入III期临床，以治疗非酒精性脂肪性肝炎（NASH）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfcb2032e4c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956096, encodeId=cf0c195609659, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Hepatology: Kupffer细胞中的YAP促进非酒精性脂肪性肝炎的进展, objectType=article, longId=197928, objectId=011419e928bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=011419e928bb, replyNumber=0, likeNumber=73, createdTime=2021-04-09, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=011419e928bb, moduleTitle=Hepatology: Kupffer细胞中的YAP促进非酒精性脂肪性肝炎的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=011419e928bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956090, encodeId=1b2f1956090c5, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Gastroenterology：belapectin用于治疗非酒精性脂肪性肝炎、肝硬化和门脉高压患者, objectType=article, longId=192704, objectId=676e192e04a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=676e192e04a1, replyNumber=0, likeNumber=68, createdTime=2020-07-04, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=676e192e04a1, moduleTitle=Gastroenterology：belapectin用于治疗非酒精性脂肪性肝炎、肝硬化和门脉高压患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=676e192e04a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956102, encodeId=8fc21956102c1, content=<a href='/topic/show?id=8a048435058' target=_blank style='color:#2F92EE;'>#脂肪性肝炎#</a>, objectTitle=Gastroenterology：减肥手术对肥胖的非酒精性脂肪性肝炎的治疗效果, objectType=article, longId=202786, objectId=6396202e8684, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6396202e8684, replyNumber=0, likeNumber=75, createdTime=2021-08-29, rootId=0, userName=Tamikia, userId=66e52500008, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6396202e8684, moduleTitle=Gastroenterology：减肥手术对肥胖的非酒精性脂肪性肝炎的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6396202e8684)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

脂肪性肝炎

2020-05-29

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Nat Med：Efruxifermin治疗非酒精性脂肪性肝炎的疗效和安全性分析

2022-01-26

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

J Clincal Gastroenterology：肾功能衰竭与非酒精性脂肪性肝炎患者的死亡率增加有关

2022-05-05

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

J Hepatol：口服FXR激动剂EDP-305治疗非酒精性脂肪性肝炎的疗效

2022-03-10

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

AJG：他汀类药物对非酒精性脂肪性肝炎肝硬化患者的肝细胞癌具有化学预防作用

2021-12-15

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

AJG：与乙型肝炎相比非酒精性脂肪性肝炎导致的肝硬化预后较差

2021-09-08

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Nat Med：Aramchol治疗非酒精性脂肪性肝炎的疗效分析

2022-04-02

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Clin Gastroenterol H：非酒精性脂肪性肝炎患者体重变化与组织学特征和血液标志物变化之间的关系

2022-02-02

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

NEJM：GLP-1受体激动剂治疗非酒精性脂肪性肝炎（NASH）：脂肪变性和肝损伤显著减轻，但纤维化改善不明显

2021-06-20

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Nat Med：Eruxifermin治疗非酒精性脂肪性肝炎的疗效如何？

2022-05-16

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Nat Med：XCR1+1型常规树突状细胞：非酒精性脂肪性肝炎的驱动因素

2021-10-13

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

JAHA：伴有非酒精性脂肪性肝炎的肥胖患者心脏形态、功能和血流动力学改变

2021-10-13

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Hepatology: 白细胞介素22可以通过改善嗜中性粒细胞驱动性非酒精性脂肪性肝炎的炎症程度

2020-12-13

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Hepatology: 肝功能不全患者缺乏肝再生蛋白会促进非酒精性脂肪性肝炎和纤维化的发生

2021-03-15

hb2008ye (审核中...)

前往app查看评论内容

#脂肪性肝炎#

非酒精性脂肪性肝炎（NASH）：歌礼生物的ASC40显著降低肝脏脂肪，响应率达61％

2020-11-19

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Cell:中山大学苏士成/许小丁/高志良发现表观遗传对于非酒精性脂肪性肝炎的关键调控作用

2021-02-16

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

NEJM：皮下注射司美鲁肽对非酒精性脂肪性肝炎的疗效

2021-06-14

智慧医人 (审核中...)

前往app查看评论内容

#脂肪性肝炎#

FDA批准候选药物lanifibranor进入III期临床，以治疗非酒精性脂肪性肝炎（NASH）

2020-12-01

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Hepatology: Kupffer细胞中的YAP促进非酒精性脂肪性肝炎的进展

2021-04-09

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Gastroenterology：belapectin用于治疗非酒精性脂肪性肝炎、肝硬化和门脉高压患者

2020-07-04

Tamikia (审核中...)

前往app查看评论内容

#脂肪性肝炎#

Gastroenterology：减肥手术对肥胖的非酒精性脂肪性肝炎的治疗效果

2021-08-29

科室
- - 订阅+
  - 更多科室
工具
服务